Stockreport

Ampio Provides Update on Results from Pre-IND Enabling Studies [Yahoo! Finance]

Ampio Pharmaceuticals, Inc.  (AMPE) 
US:NASDAQ Investor Relations: ampiopharma.com
PDF biopharmaceutical company focused on development of a potential treatment for osteoarthritis as part of its OA-201 program, today announced the efficacy results from rec [Read more]